Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.
about
Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast CancerDeep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness AnalysisA Systematic Review and Network Meta-Analysis of Biologic Agents in the First Line Setting for Advanced Colorectal CancerThe broader economic impact of vaccination: reviewing and appraising the strength of evidenceOpen urethroplasty versus endoscopic urethrotomy--clarifying the management of men with recurrent urethral stricture (the OPEN trial): study protocol for a randomised controlled trialUsing meta-regression analyses in addition to conventional systematic review methods to examine the variation in cost-effectiveness results - a case studyCalculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology AppointmentOxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness AnalysisToward an integrated meta-model of public health dynamics for preparedness decision supportGetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world.Risk of bias in model-based economic evaluations: the ECOBIAS checklist.Modeling the costs and benefits of capnography monitoring during procedural sedation for gastrointestinal endoscopy.Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.Testing previous model predictions against new data on human papillomavirus vaccination program outcomes.Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?Methods to construct a step-by-step beginner's guide to decision analytic cost-effectiveness modeling.A systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Current challenges in health economic modeling of cancer therapies: a research inquiry.Economic evaluations of guideline-based or strategic interventions for the prevention or treatment of chronic woundsModeling and calibration for exposure to time-varying, modifiable risk factors: the example of smoking behavior in India.Validation of the IHE Cohort Model of Type 2 Diabetes and the impact of choice of macrovascular risk equationsBiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesDay hospital Mentalization-based treatment versus intensive outpatient Mentalization-based treatment for patients with severe borderline personality disorder: protocol of a multicentre randomized clinical trial.Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerThe Brighton declaration: the value of non-communicable disease modelling in population health sciencesA cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation.Relationship between modeling technique and reported outcomes: case studies in models for the treatment of schizophrenia.Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings.Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments.Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluationsEffectiveness, cost-effectiveness and cost-benefit of a single annual professional intervention for the prevention of childhood dental caries in a remote rural Indigenous community.A qualitative study on the views of experts regarding the incorporation of non-health outcomes into the economic evaluations of public health interventions.Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic ReviewDecision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer.Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol.AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model UsersGood Practices in Model-Informed Drug Discovery and Development: Practice, Application, and DocumentationConsensus Statement on Electronic Health Predictive Analytics: A Guiding Framework to Address Challenges.Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions.
P2860
Q26748855-B2183122-0FE3-40AA-916A-9CB98E7FDFE7Q26779605-EB62EDB4-D8C5-4BA3-B7BB-C8B969E4C1A8Q26782245-4ACFF78F-B064-450F-AFB9-9EBA63087D41Q26786095-055CCB29-366D-4DC1-9599-9FF530F913ECQ27334907-50C25914-A9E3-4BB1-AE84-903E872DE80BQ28066022-0BDFBAB4-BC2A-483B-B50C-3DE23CAD781AQ28603996-2BE4032E-F198-4D15-9AF8-7F98CF55B4F0Q29353660-10CA379F-9E04-4E03-9614-7004B17009ECQ30221911-B1ECDF05-B288-4A46-9BFD-D080AFDE46BDQ30248472-F87E1411-F2A3-4450-A9EB-115E6EA99F19Q30252032-DB4345F2-7DA6-48E6-BD84-BA49651AE76AQ30388023-9AFDA064-5FB2-4DF1-B3AE-817717B73115Q30595581-860DD078-BB05-4234-8984-F250B6785D60Q30764433-5341BC71-88AD-4CC4-84E0-4D392E13C969Q30768230-A133E675-7B01-4B4E-AC2F-22AEFF464958Q30823226-EF0866B5-6AB2-4BF9-8F63-514DD86E1B3DQ33413196-E54DA53C-089A-4764-B6C6-6C5685BE1527Q33805471-24A5E70A-3B3E-4E70-9CAA-F44E1E1965F0Q33947659-147B3CDC-482E-4207-BC49-78A11960E8AFQ33969384-516407C5-77F2-4112-A84F-6C9EEAD6510BQ34332236-26527E3A-0748-4B8B-B833-38A096148203Q34340697-2B4158DD-2C8E-4862-80F0-4951A4DEF119Q34558784-BEDEA085-1389-401C-8B76-0350923E2321Q34573853-111B2024-6E3D-4C0B-90EE-58C99C34AA71Q34778413-3820BB57-5ED2-4E11-BC48-7C3CC578BDE4Q35048588-2D7974D5-31D0-41A4-9503-7101653D60E7Q35101645-D17B28B9-233B-446F-AE22-DA56D00C63F6Q35630911-99F6FFD5-0520-418C-A255-BC9EB3C503A3Q35655056-4F05B5B6-98B8-45A7-9AF4-3B94929B8D53Q35665481-DFA87BCD-7BE4-4DFA-8361-83D5910A50E4Q35759305-C43FE235-9BA9-41E7-8328-C4B02FCF7493Q35785654-F96712BD-601D-4BEB-883C-CD76C4CD56EBQ35954700-BB69F3B1-6160-4D75-8CC3-F0AA7DE53E82Q36149920-44D2B6D4-0091-49F5-B4DB-89E84D6D4E02Q36177951-8986FEBD-3D6F-4D56-8581-0F56025280AFQ36302726-4FD08657-DB83-4EE2-89C9-DC6DDFF09DFCQ36698876-E5CFBD17-97C9-4E5C-9AF1-D63B59DDF5CCQ36734132-91FBE9E6-1A90-42E0-A252-94D86A31E8DCQ36816489-7AB32B3B-9588-403D-8107-34E8F92B3982Q36871294-D78B99CC-ED44-410E-AF27-18AD29F8352F
P2860
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Modeling good research practic ...... earch Practices Task Force--1.
@en
Modeling good research practic ...... earch Practices Task Force--1.
@nl
type
label
Modeling good research practic ...... earch Practices Task Force--1.
@en
Modeling good research practic ...... earch Practices Task Force--1.
@nl
prefLabel
Modeling good research practic ...... earch Practices Task Force--1.
@en
Modeling good research practic ...... earch Practices Task Force--1.
@nl
P2093
P1433
P1476
Modeling good research practic ...... earch Practices Task Force--1.
@en
P2093
Andrew H Briggs
ISPOR-SMDM Modeling Good Research Practices Task Force
Karen M Kuntz
Uwe Siebert
P304
P356
10.1016/J.JVAL.2012.06.012
P50
P577
2012-09-01T00:00:00Z